Newsroom
307 articles
FeaturedThe U.S. Food and Drug Administration authorized Ryoncil (remestemcel-L-rknd), an allogeneic (donor) bone marrow-derived mesenchymal stromal cell (MSC) therapy in order to steroid-refractory acute graft-versus-host disease (SR-aGVHD) in…
FeaturedThe U.S. Food and Drug Administration authorized the use of Crenessity (crinecerfont) in conjunction with glucocorticoids (steroids) to regulate the levels of androgen (a testosterone-like hormone) in adults…
FeaturedA recent study’s findings indicate that Alofisel, a medication used to treat complex anal fistulas in adults with Crohn’s disease, is ineffective. Based on the information at hand,…
FeaturedThe European Medicines Agency (EMA) has suggested that Welireg (belzutifan) be given a conditional marketing authorization in the EU for people with advanced renal cancer (RCC) who have…
FeaturedEuropean Medicines Agency (EMA) has recommended granting a marketing authorization in the European Union (EU) for Emcitate (tiratricol), an oral medication for individuals with peripheral thyrotoxicosis (unreasonably elevated…
FeaturedThe Holiday season is a busy time for all of us, our friends and our family. Consequently, we could overlook our health in the chaos to make sure…
FeaturedThe European Medicines Agency (EMA) has suggested expanding the use of Ofev (nintedanib) to treat progressive fibrosing interstitial lung disorders (ILDs) in children and adolescents starting at age…
FeaturedThe updated regulatory framework will expedite trial approvals and promote trial design innovation without affecting patient safety. New laws will be introduced in Parliament to address the need…
FeaturedThe Medicines and Healthcare products Regulatory Agency (MHRA) has approved the medicine flortaucipir (Tauvid), a radiopharmaceutical product given to adults with memory problems so that doctors can perform…
FeaturedFollowing a review of its initial opinion, EMA suggests revising the recommendations to reduce the possibility of interactions between the weight loss medication Mysimba (naltrexone/bupropion) and medications that…
FeaturedThe U.S. Food and Drug Administration approved Kebilidi (eladocagene exuparvovec-tneq), a gene therapy based on an adeno-associated virus vector that is recommended for the treatment of patients with…
FeaturedThe Medicines and Healthcare products Regulatory Agency (MHRA) has approved new medicine containing active ingredient sparsentan to treat primary immunoglobulin A nephropathy (IgAN). IgA neuropathy, also known as…
FeaturedAfter an agency analysis of the available evidence found that oral phenylephrine is ineffective for this use, The U.S. Food and Drug Administration announced is proposing to remove…
FeaturedThe Medicines and Healthcare Products Regulatory Agency (MHRA) is advising medical practitioners to make sure patients are informed about the known adverse effects of agonists of the glucagon-like…
FeaturedSugemalimab, also known as(Equijubi), has been approved by the Medicines and Healthcare Products Regulatory Agency (MHRA) to treat adult patients with “non-small cell lung cancer.” Non-small cell lung…
Talk to our experts and get tailored solutions to help you stay compliant and move forward with confidence.
Submit RFI/RFP
Request Consultation
Submit RFI/RFP